You are here

P&T News

May 21

U.S. News & World Report devises yet another form of quality ranking
New study evaluates treatment in advanced disease
Pennsylvania hospital offers some tips

May 20

Indacaterol/glycopyrronium meets all endpoints in late-stage trial
Disproportionate-share facilities struggle as federal funds shrink
First four-times-a-year treatment for schizophrenia
Resistance to bisphosphocins appears to be impossible, company says

May 19

Guidelines are for average-risk adults without symptoms
U.S. News analysis finds above-average deaths for common procedures
Study compares propofol with midazolam/fentanyl combo
Device reminds patients when doses are missed
Topical interleukin-1 receptor blocker treats inflammatory dry eye disease

May 18

Antibiotic therapies used inappropriately nearly half the time
Five studies highlight “smarter screening” techniques
Patients may need fewer and less-invasive tests
Medication reduces pulmonary exacerbations by nearly 40%
The up-side to costly new treatments: $3.2 billion in annual productivity savings

Pages